로딩 중…
지수 로딩 중…
ClearPoint Neuro, Inc.
CLPT· NASDAQ· Health Care· Health Care Equipment & Services
$15.38+2.95%
2026-08-03
Financials
Valuation Metrics
ClearPoint Neuro, Inc.'s Market Cap is $461M. At end of 2025 it was $387M. Ranked #2832 of 3,111 in US market (top 91%), #1240 of 1,445 on NASDAQ (top 86%), #172 of 206 in Health Care Equipment & Services (top 83%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $461M | US#2,832/3,111 Sec#172/206 |
| Revenue | $41M | US#2,880/3,111 Sec#201/206 |
| Net Income | $-29M | US—/3,111 Sec—/206 |
| Total Assets | $93M | US#3,051/3,111 Sec#205/206 |
| Net Assets | $19M | US#2,986/3,111 Sec#201/206 |
| Value | ||
| P/B | 24.48x | US#2,853/3,111 Sec#190/206 |
| P/S | 11.36x | US#2,699/3,111 Sec#190/206 |
| FCF Yield | -5.79% | US—/3,111 Sec—/206 |
| Profitability | ||
| ROE | -154.27% | US#2,895/3,111 Sec#192/206 |
| ROA | -31.11% | US#2,887/3,111 Sec#191/206 |
| Op. Margin | -65.20% | US#2,792/3,111 Sec#192/206 |
| Revenue Growth | 42.93% | US#344/3,111 Sec#17/206 |
| Financial Health | ||
| Debt Ratio | 395.81% | US#2,284/3,111 Sec#182/206 |
| Total Debt | $64M | US#2,523/3,111 Sec#146/206 |
| FCF | $-27M | US#2,402/3,111 Sec#168/206 |
| Cash | $36M | US#2,722/3,111 Sec#182/206 |
| Current Ratio | 5.79x | US#415/3,111 Sec#31/206 |
| Performance | ||
| 1Y Return | 53.80% | US#821/3,111 Sec#60/206 |
| 1M Return | -17.84% | US#2,841/3,111 Sec#190/206 |
| From 52W High | -48.90% | US#2,754/3,111 Sec#179/206 |
| 1Y MDD | -70.74% | US#2,927/3,111 Sec#188/206 |
| Trading | ||
| Volume | 492,755 shares | US#1,875/3,111 Sec#120/206 |
| Trading Value | $7M | US#2,359/3,111 Sec#156/206 |
| Per Share | ||
| EPS | $-0.90 | US—/3,111 Sec—/206 |
| BPS | $0.99 | US#2,629/3,111 Sec#180/206 |